The Louisiana Department of Health - Office of Public Health (LDH-OPH) is seeking to procure a Molecular Diagnostics Analyzer rental through an Invitation to Bid (ITB) solicitation number 3000024682, specifically targeting an Abbott Alinity M System (Model #08N5302) with associated consumables and accessories. The procurement covers an initial 12-month contract period beginning July 1, 2025, with potential two 12-month renewals, totaling a maximum 36-month contract duration. The analyzer must be FDA approved or emergency use authorized, capable of performing multiplex tests for COVID-19, Influenza A, Influenza B, and potentially RSV, with an anticipated annual testing volume of 1,250 tests. Required technical specifications include a built-in barcode scanner, touchscreen computer, printer, and the ability to detect various virus strains including emerging COVID-19 variants. The bid will be awarded on an all-or-none basis to the lowest responsive and responsible bidder meeting detailed performance specifications, with the system required to provide first results within 115 minutes and support nasal and nasopharyngeal swab samples. The bid opening is scheduled for May 20, 2025, at 10:00 AM CST, with both electronic and physical submission options available through the LaGov vendor system. The procurement offers preferences for Louisiana-based businesses, with bidders qualifying for preference if their workforce is at least 50% Louisiana residents and potentially receiving pricing considerations for Louisiana-produced products. Vendors must be registered in the LaGov system and comply with various state and federal requirements, including civil rights laws and ADA accessibility standards. The contract is funded through next fiscal year appropriations, contingent on legislative funding, which means delivery cannot occur prior to July 1, 2025. All products must be new, current models, and include the manufacturer's standard warranty, with pricing required to be inclusive of freight charges and remain firm for the entire contract period. While specific budget ranges are not explicitly detailed, the comprehensive nature of the procurement suggests a substantial investment in molecular diagnostic testing capabilities for the Louisiana Department of Health. State agencies will be exempt from state and local sales taxes, and the procurement emphasizes minimizing human error through advanced system features like reagent bottle design and operator lockouts.
Name | Description | Size | Type (Click to sort descending) | Posted (Click to sort descending) |
|---|---|---|---|---|
3000024682.pdf | 150KB | 5/1/25 | ||
Attachment C - Online Bidding Instructions - Pages 1-10.pdf | 1MB | 5/1/25 | ||
Attachment A - Special Terms and Conditions - Pages 1-7.pdf | 208KB | 5/1/25 | ||
Attachment B - Specifications - Pages 1-2.docx | 16KB | Document | 5/1/25 |